Molecular Human Reproduction, Vol. 6, No. 11, 1033-1040,
November 2000
© 2000 European Society of Human Reproduction and Embryology
Pregnancy |
Prostaglandin E2-dependent production of latent matrix metalloproteinase-9 in cultures of human fetal membranes
Preterm Birth Research Group, Department of Obstetrics and Gynaecology, University of Leicester, PO Box 65, Leicester LE2 7LX, UK
Abstract
Studies in our laboratory have shown that structural changes in cervical biopsied fetal membranes, prior to labour, coincide with differences in the expression of the gelatinase enzyme, latent matrix metalloproteinase-9 (MMP-9). Concurrently, in vivo, there is an increase in the expression of prostaglandins, notably prostaglandin E2 (PGE2), which has been shown to regulate the expression of MMPs in other systems. The aim of this study was to test the hypothesis (using an in-vitro culture model) that endogenously produced PGE2 has a role in the elevation of MMP-9 described in vivo. Non-infected fetal membranes sampled from women undergoing elective Caesarean section were stimulated with 10% (v/v) fetal bovine serum (FBS), a known inducer of prostaglandins. This activation resulted in a time-dependent increase in the secretion of PGE2 into the media, as determined by enzyme-linked immunosorbent assay (day 1: 19 ± 9 pg/ml/24 h to 358 ± 54 pg/ml/24 h by day 4). A similar pattern of secretion of latent MMP-9 was observed in parallel with the increase in PGE2 in the same culture media (day 1: 1.63 ± 0.17 ng/ml/24 h to 4.2 ± 1.4 ng/ml/24 h by day 4). When both molecules were compared, a significant (P < 0.01) positive correlation (r = 0.623) was observed. Secretion of the tissue inhibitor of MMPs-9 (TIMP-1) was not significantly different between untreated (3.07 ± 0.266 µg/ml/24 h) and FBS-treated (3.85 ± 0.24 µg/ml/24 h) cultures during the first 4 days in culture. Prostaglandin synthesis inhibition studies using indomethacin (100 µmol/l) resulted in a 70–80% reduction in the activated secretion of latent MMP-9. Direct PGE2 stimulation of cultures resulted in the bell shaped dose–response curve with concentrations of 1–100 nmol/l (which are within the range secreted in culture in response to FBS), stimulating significant latent MMP-9 secretion. These results suggest a link between endogenous PGE2 and latent MMP-9 production in human fetal membranes, raising the possibility that PGE2 has a role in the mechanism of fetal membrane structural changes and, hence, in parturition-associated membrane rupture.
human fetal membranes/indomethacin/MMP/parturition/prostaglandin E2
Notes
1 To whom correspondence should be addressed at: Preterm Birth Research Group, Department of Obstetrics and Gynaecology, University of Leicester, PO Box 65, Leicester LE2 7LX, UK. E-mail: jm50{at}leicester.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Alfranca, J. M. Lopez-Oliva, L. Genis, D. Lopez-Maderuelo, I. Mirones, D. Salvado, A. J. Quesada, A. G. Arroyo, and J. M. Redondo PGE2 induces angiogenesis via MT1-MMP-mediated activation of the TGF{beta}/Alk5 signaling pathway Blood, August 15, 2008; 112(4): 1120 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Szymczak, M. Murray, and N. Petrovic Modulation of angiogenesis by {omega}-3 polyunsaturated fatty acids is mediated by cyclooxygenases Blood, April 1, 2008; 111(7): 3514 - 3521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Li, E. Unlugedik, A. D. Bocking, and J. R.G. Challis The Role of Prostaglandins in the Mechanism of Lipopolysaccharide-Induced proMMP9 Secretion from Human Placenta and Fetal Membrane Cells Biol Reprod, April 1, 2007; 76(4): 654 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Li and J. R. G. Challis Corticotropin-Releasing Hormone and Urocortin Induce Secretion of Matrix Metalloproteinase-9 (MMP-9) without Change in Tissue Inhibitors of MMP-1 by Cultured Cells from Human Placenta and Fetal Membranes J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6569 - 6574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Oger, C. Mehats, E. Dallot, D. Cabrol, and M.-J. Leroy Evidence for a Role of Phosphodiesterase 4 in Lipopolysaccharide-Stimulated Prostaglandin E2 Production and Matrix Metalloproteinase-9 Activity in Human Amniochorionic Membranes J. Immunol., June 15, 2005; 174(12): 8082 - 8089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Swarnakar, K. Ganguly, P. Kundu, A. Banerjee, P. Maity, and A. V. Sharma Curcumin Regulates Expression and Activity of Matrix Metalloproteinases 9 and 2 during Prevention and Healing of Indomethacin-induced Gastric Ulcer J. Biol. Chem., March 11, 2005; 280(10): 9409 - 9415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Menon and S. J. Fortunato The Role of Matrix Degrading Enzymes and Apoptosis in Repture of Membranes Reproductive Sciences, October 1, 2004; 11(7): 427 - 437. [Abstract] [PDF]
|
|
|
|
|
|
W. Li, N. Alfaidy, and J. R. G. Challis Expression of Extracellular Matrix Metalloproteinase Inducer in Human Placenta and Fetal Membranes at Term Labor J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2897 - 2904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Kashiwagi and S Tsukahara Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost Br. J. Ophthalmol., March 1, 2003; 87(3): 297 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ichihara, T. Senbonmatsu, E. Price Jr, T. Ichiki, F. A. Gaffney, and T. Inagami Targeted Deletion of Angiotensin II Type 2 Receptor Caused Cardiac Rupture After Acute Myocardial Infarction Circulation, October 22, 2002; 106(17): 2244 - 2249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Xu, N. Alfaidy, and J. R. G. Challis Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Human Placenta and Fetal Membranes in Relation to Preterm and Term Labor J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1353 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Ulug, S. Goldman, I. Ben-Shlomo, and E. Shalev Matrix metalloproteinase (MMP)-2 and MMP-9 and their inhibitor, TIMP-1, in human term decidua and fetal membranes: the effect of prostaglandin F2{alpha} and indomethacin Mol. Hum. Reprod., December 1, 2001; 7(12): 1187 - 1193. [Abstract] [Full Text] [PDF]
|
|